These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17763181)

  • 21. Adipokines in diabetes and cardiovascular diseases.
    Kralisch S; Sommer G; Deckert CM; Linke A; Bluher M; Stumvoll M; Fasshauer M
    Minerva Endocrinol; 2007 Sep; 32(3):161-71. PubMed ID: 17912155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adiponectin, an adipocyte-derived protein.
    Nedvídková J; Smitka K; Kopský V; Hainer V
    Physiol Res; 2005; 54(2):133-40. PubMed ID: 15544426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional significance of skeletal muscle adiponectin production, changes in animal models of obesity and diabetes, and regulation by rosiglitazone treatment.
    Liu Y; Chewchuk S; Lavigne C; Brûlé S; Pilon G; Houde V; Xu A; Marette A; Sweeney G
    Am J Physiol Endocrinol Metab; 2009 Sep; 297(3):E657-64. PubMed ID: 19531641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of chronic acarbose treatment on adipocyte insulin responsiveness, serum levels of leptin and adiponectin and hypothalamic NPY expression in obese diabetic Wistar rats.
    Pérez C; Fernández-Agulló T; De Solís AJ; Ros M; Andrés A; Carrascosa JM
    Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):256-61. PubMed ID: 18290871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of resistin in obesity-induced insulin resistance.
    Haluzik M; Haluzikova D
    Curr Opin Investig Drugs; 2006 Apr; 7(4):306-11. PubMed ID: 16625816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postprandial response of ghrelin and PYY and indices of low-grade chronic inflammation in lean young women with polycystic ovary syndrome.
    Zwirska-Korczala K; Sodowski K; Konturek SJ; Kuka D; Kukla M; Brzozowski T; Cnota W; Woźniak-Grygiel E; Jaworek J; Bułdak R; Rybus-Kalinowska B; Fryczowski M
    J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():161-78. PubMed ID: 18812636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adiponectin: an update.
    Guerre-Millo M
    Diabetes Metab; 2008 Feb; 34(1):12-8. PubMed ID: 18069030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New insights into thiol-mediated regulation of adiponectin secretion.
    Wolf G
    Nutr Rev; 2008 Nov; 66(11):642-5. PubMed ID: 19019026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adiponectin: from obesity to cardiovascular disease.
    Antoniades C; Antonopoulos AS; Tousoulis D; Stefanadis C
    Obes Rev; 2009 May; 10(3):269-79. PubMed ID: 19389061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adiponectin and interleukin-6 in inflammation-associated disease.
    Li L; Wu LL
    Vitam Horm; 2012; 90():375-95. PubMed ID: 23017723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fat depot-specific impact of visceral obesity on adipocyte adiponectin release in women.
    Drolet R; Bélanger C; Fortier M; Huot C; Mailloux J; Légaré D; Tchernof A
    Obesity (Silver Spring); 2009 Mar; 17(3):424-30. PubMed ID: 19219061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flaxseed lignan attenuates high-fat diet-induced fat accumulation and induces adiponectin expression in mice.
    Fukumitsu S; Aida K; Ueno N; Ozawa S; Takahashi Y; Kobori M
    Br J Nutr; 2008 Sep; 100(3):669-76. PubMed ID: 18252024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human obesity and insulin resistance: lessons from experiments of nature.
    O'Rahilly S
    Novartis Found Symp; 2007; 286():13-20; discussion 20-3, 162-3, 196-203. PubMed ID: 18269171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adiponectin in health and disease: evaluation of adiponectin-targeted drug development strategies.
    Shetty S; Kusminski CM; Scherer PE
    Trends Pharmacol Sci; 2009 May; 30(5):234-9. PubMed ID: 19359049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A hypothesis: adiponectin mediates anti-atherosclerosis via adventitia-AMPK-iNOS pathway.
    Cai XJ; Li CJ; Chen L; Rong YY; Zhang Y; Zhang M
    Med Hypotheses; 2008; 70(5):1044-7. PubMed ID: 17910991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The physiological and pathophysiological role of adiponectin and adiponectin receptors in the peripheral tissues and CNS.
    Kadowaki T; Yamauchi T; Kubota N
    FEBS Lett; 2008 Jan; 582(1):74-80. PubMed ID: 18054335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glycine increases mRNA adiponectin and diminishes pro-inflammatory adipokines expression in 3T3-L1 cells.
    Garcia-Macedo R; Sanchez-Muñoz F; Almanza-Perez JC; Duran-Reyes G; Alarcon-Aguilar F; Cruz M
    Eur J Pharmacol; 2008 Jun; 587(1-3):317-21. PubMed ID: 18499099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-inflammatory and anti-atherogenic properties of adiponectin.
    Ohashi K; Ouchi N; Matsuzawa Y
    Biochimie; 2012 Oct; 94(10):2137-42. PubMed ID: 22713764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adiponectin: a biomarker of obesity-induced insulin resistance in adipose tissue and beyond.
    Lu JY; Huang KC; Chang LC; Huang YS; Chi YC; Su TC; Chen CL; Yang WS
    J Biomed Sci; 2008 Sep; 15(5):565-76. PubMed ID: 18535923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of adiponectin as a potential therapeutic strategy.
    Lim S; Quon MJ; Koh KK
    Atherosclerosis; 2014 Apr; 233(2):721-728. PubMed ID: 24603219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.